Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome (ISAR-REACT 5)
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Sponsor: Deutsches Herzzentrum Muenchen
Listed as NCT01944800, this PHASE4 trial focuses on Acute Coronary Syndrome (ACS) and remains completed. Sponsored by Deutsches Herzzentrum Muenchen, it has been updated 11 times since 2013, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2021 — Mar 2023 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE4
-
Aug 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Jun 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
Apr 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Apr 2017 [monthly]
Recruiting PHASE4
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsches Herzzentrum Muenchen
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Krozingen, Germany , Bad Nauheim, Germany , Bad Segeberg, Germany , Berlin, Germany , Erding, Germany , Florence, Italy , Frosinone, Italy , Göttingen, Germany , Heidelberg, Germany , Kiel, Germany and 6 more locations